Assay of naproxen by high-performance liquid chromatography and identification of its photoproducts by LC-ESI MS

Biomedical Chromatography

Volumn 20, Issue 8, 2006, Pages 787-793

  Hsu, Yi Hsin ^a   Liou, Yi Bo ^b   Lee, Jen Ai ^b   Chen, Chau Yang ^c   Wu, An Bang ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

Author keywords

HPLC; LC ESI MS; Naproxen; Photoproducts; Validation

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SOURCES;

COEFFICIENT OF VARIANCE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; LC-ESI-MS; LC/ESI-MS; NAPROXENS; PERFORMANCE; PHOTOPRODUCTS; REVERSED-PHASE HIGH PERFORMANCE; VALIDATION;

METHANOL;

1 (6 METHOXYNAPHTHALEN 2 YL)ETHANOL; 1 (6 METHOXYNAPHTHALEN 2 YL)ETHANONE; 2 (6 METHOXYNAPHTHALEN 2 YL)PROPANOIC ACID; 2 ETHYL 6 METHOXYNAPHTHALENE; ACETONITRILE; INDOMETACIN; METHANOL; METHYL 2 (6 METHOXYNAPHTHALEN 2 YL)PROPANOATE; NAPROXEN; NAPROXEN DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; COLUMN CHROMATOGRAPHY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; PHOTODEGRADATION; QUANTITATIVE ANALYSIS; RADIATION DETECTION; RELIABILITY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 33746968555     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.598     Document Type: Article

References (18)

1. Anderson JV and Hansen SH. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica. Journal of Chromatography: Biomedical Applications 1992; 115: 525.
2. Chen CY, Chen FA, Chen CJ, Wu KH and Wu AB. Stability-indicating HPLC assay method of zomepirac. Journal of Food and Drug Analysis 2003a; 11(4): 87.
3. Chen FA, Chen CY, Chen CJ and Wu AB. Quantitation of tolmetin by high-performance liquid chromatography and method validation. Journal of Chromatographic Science 2003b; 41(7): 381.
4. Ekpe A, Tong JH and Rodriguez L. High-performance liquid chromatographic method development and validation for the simultaneous quantitation of naproxen sodium and pseudoephedrine hydrochloride impurities. Journal of Chromatographic Science 2001; 39(3): 81.
5. Harrison IT, Lewis B, Nelson P, Rooks W, Roszkowski A, Tomolonis A and Fried JH. Nonsteroidal anti-inflammatory agents. I. 6-Substituted 2-naphthylacetic acids. Journal of Medicinal Chemistry 1970; 13: 203.
6. Ho HT, Liou YB, Lin PY, Wang PY, Lin DZL and Wu AB. Photolysis of NSAIDs. V. Photoproducts of naproxen in alcoholic solvents. Sixth Tetrahedron Symposium. Challenges in Organic Chemistry, Bordeaux, France, poster abstract no. 58, 2005; 140.
7. Hsu HC and Chen CS. Validation of analytical methods: a simple model for HPLC assay methods. Journal of Food and Drug Analysis 1994; 2(3): 161.
8. Kao YH, Kuo SC and Jia SW. Analysis of drug consumption and prescribing dose in NHI, using non-steroidal anti-inflammatory drugs and serum lipid reducing agents as models, Research Project (DOH90-NH-018) Report. Department of Health, Executive Yuan, Taipei, Taiwan, 2003.
9. Mikami E, Goto T, Ohno T, Matsumoto H and Nishida M. Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 2000; 23(5): 917.
10. Moir DB, Beaulieu N, Curran NM and Lovering EG. Liquid chromatographic determination of naproxen and related compounds in raw materials. Journal of the Association of Officical Analytical Chemistry 1990; 73(6): 902.
11. Monser L and Darghouth F. Simultaneous determination of naproxen and related compounds by HPLC using porous graphitic carbon column. Journal of Pharmaceutical and Biomedical Analysis 2003; 32(4-5): 1087.
12. Peswani KS and Lalla JK. Naproxen parenteral formulation studies. Journal of Parenteral Science Technology 1990; 44(6): 336.
13. Sidelman UG, Bjornsdottir I, Schockcor JP, Hansen SH, Lindon JC and Nicholson JK. Direct coupled HPLC-NMR and HPLC-MS approaches for the rapid characterization of drug metablites in urine: application to the human metabolism of naproxen. Journal of Pharmaceutical and Biomedical Analysis 2001; 24(4): 569.
14. Streete PJ. Rapid high-performance liquid chromatographic methods for the determination of overdose concentrations of some non-steroidal anti-inflammatory drugs in plasma or serum. Journal of Chromatography: Biomedical Applications 1989; 495: 179.
15. Tashtoush BM and Al-Taani BM. HPLC determination of naproxen in plasma. Pharmazie 2003; 58(9): 614.
16. van Loenhout JWA, van Ginneken CAM, Ketelaars HCJ, Kimenai PM, Tan Y and Gribnau FWJ. A high-performance liquid chromatographic method for the quantitative determination of naproxen and des-methyl-naproxen in biological samples. Journal of Liquid Chromatography 1982; 5(3): 549.
17. Wan SH and Matin SB. Quantitative gas-liquid chromatographic analysis of naproxen, 6-O-desmethyl-naproxen and their conjugates in urine. Journal of Chromatography 1979; 170(2): 473.
18. Wu AB, Chen CY, Chu SD, Tsai YC and Chen FA. Stability-indicating HPLC assay method and photostability of carprofen. Journal of Chromatographic Science 2001; 39(1): 7.